<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sahoo PK</submitter><funding>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</funding><funding>Merkin Peripheral Neuropathy and Nerve Regeneration Center</funding><funding>HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</funding><funding>University of South Carolina Vice President for Research Office</funding><funding>South Carolina Spinal Cord Injury Research Fund</funding><funding>South Carolina Spinal Cord Injury Research Fund (SCIRF)</funding><funding>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)</funding><funding>HHS | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>George W. Neilson Foundation</funding><funding>NINDS NIH HHS</funding><pagination>e2411811122</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11892601</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>122(9)</volume><pubmed_abstract>Depletion or inhibition of core stress granule proteins, G3BP1 in mammals and TIAR-2 in &lt;i>Caenorhabditis elegans&lt;/i>, increases the growth of spontaneously regenerating axons. Inhibition of G3BP1 by expression of its acidic or "B-domain" accelerates axon regeneration after nerve injury, bringing a potential therapeutic strategy for peripheral nerve repair. Here, we asked whether G3BP1 inhibition is a viable strategy to promote regeneration in injured mammalian central nervous system (CNS) where axons do not regenerate spontaneously. G3BP1 B-domain expression was found to promote axon regeneration in the transected spinal cord provided with a permissive peripheral nerve graft (PNG) as well as in crushed optic nerve. Moreover, a cell-permeable peptide (CPP) to a subregion of B-domain (roden</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Disruption of G3BP1 granules promotes mammalian CNS and PNS axon regeneration.</pubmed_title><pmcid>PMC11892601</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>R01-NS0117821</funding_grant_id><funding_grant_id>733151</funding_grant_id><funding_grant_id>R01 NS117821</funding_grant_id><pubmed_authors>Hanovice N</pubmed_authors><pubmed_authors>Twiss JL</pubmed_authors><pubmed_authors>Sahoo PK</pubmed_authors><pubmed_authors>Desai M</pubmed_authors><pubmed_authors>Ward PJ</pubmed_authors><pubmed_authors>Benowitz LI</pubmed_authors><pubmed_authors>Dulin JN</pubmed_authors><pubmed_authors>Tuszynski MH</pubmed_authors><pubmed_authors>Smith TP</pubmed_authors><pubmed_authors>Vaughn LS</pubmed_authors><pubmed_authors>English AW</pubmed_authors><pubmed_authors>Agrawal M</pubmed_authors><pubmed_authors>SiMa H</pubmed_authors><pubmed_authors>Houle JD</pubmed_authors><pubmed_authors>Welshhans K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disruption of G3BP1 granules promotes mammalian CNS and PNS axon regeneration.</name><description>Depletion or inhibition of core stress granule proteins, G3BP1 in mammals and TIAR-2 in &lt;i>Caenorhabditis elegans&lt;/i>, increases the growth of spontaneously regenerating axons. Inhibition of G3BP1 by expression of its acidic or "B-domain" accelerates axon regeneration after nerve injury, bringing a potential therapeutic strategy for peripheral nerve repair. Here, we asked whether G3BP1 inhibition is a viable strategy to promote regeneration in injured mammalian central nervous system (CNS) where axons do not regenerate spontaneously. G3BP1 B-domain expression was found to promote axon regeneration in the transected spinal cord provided with a permissive peripheral nerve graft (PNG) as well as in crushed optic nerve. Moreover, a cell-permeable peptide (CPP) to a subregion of B-domain (roden</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-01T18:01:28.876Z</modification><creation>2025-04-04T02:54:28.158Z</creation></dates><accession>S-EPMC11892601</accession><cross_references><pubmed>40014573</pubmed><doi>10.1073/pnas.2411811122</doi></cross_references></HashMap>